NOX as a Therapeutic Target in Liver Disease
The nicotinamide adenine dinucleotide phosphate hydrogen oxidase (NADPH oxidase or NOX) plays a critical role in the inflammatory response and fibrosis in several organs such as the lungs, pancreas, kidney, liver, and heart. In the liver, NOXs contribute, through the generation of reactive oxygen sp...
Main Authors: | Deyamira Matuz-Mares, Héctor Vázquez-Meza, María Magdalena Vilchis-Landeros |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/11/10/2038 |
Similar Items
-
The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Cell Biology in Health and Disease
by: Macarena Herranz-Itúrbide, et al.
Published: (2021-09-01) -
Glutathione Participation in the Prevention of Cardiovascular Diseases
by: Deyamira Matuz-Mares, et al.
Published: (2021-07-01) -
The Role of NOX4 and TRX2 in Angiogenesis and Their Potential Cross-Talk
by: Chaofei Chen, et al.
Published: (2017-06-01) -
Tuberculous Fibrosis Enhances Tumorigenic Potential via the NOX4–Autophagy Axis
by: Seong Ji Woo, et al.
Published: (2021-02-01) -
Dexamethasone inhibits the Nox-dependent ROS production <it>via </it>suppression of MKP-1-dependent MAPK pathways in activated microglia
by: Ling Eng-Ang, et al.
Published: (2011-05-01)